Clinical trials / NCT07539597
Recruiting

Innovative Approaches to Hypertension Management in High-Risk Emergency Department Populations

This single-center, single-arm quasi-experimental study will assess the feasibility and acceptability of a community health worker (CHW)-led intervention to address social determinants of health (SDOH) among emergency department patients with hypertension. At enrollment, participants (N=15) will complete standardized SDOH surveys in REDCap, and CHWs will facilitate referrals to local community-based organizations that address identified social needs. With participant consent, the study will also include medical…

ClinicalTrials.gov IDNCT07539597
PhaseNA
Enrollment15
SponsorIcahn School of Medicine at Mount Sinai
Age18 Years
SexALL
I'm interested View official listing

Conditions studied

Asymptomatic Hypertension

About this study

This single-center, single-arm quasi-experimental study will assess the feasibility and acceptability of a community health worker (CHW)-led intervention to address social determinants of health (SDOH) among emergency department patients with hypertension. At enrollment, participants (N=15) will complete standardized SDOH surveys in REDCap, and CHWs will facilitate referrals to local community-based organizations that address identified social needs. With participant consent, the study will also include medical record review through EPIC and Healthix to evaluate healthcare utilization-including emergency department visits, hospitalizations, and outpatient encounters-during the one-year period before and after the index ED visit.

Interventions

Primary outcomes

Eligibility information

Inclusion Criteria: * 18 years and older who reside in the 5 boroughs of NYC, * whom speak English or Spanish, * have a known diagnosis of hypertension, and * have uncontrolled hypertension, defined as two measures of systolic blood pressure (SBP) ≥140 mmHg or diastolic blood pressure (DBP) ≥ 90 mmHg obtained during their ED visit. Exclusion Criteria: * Patients who are unable to consent, * pregnant patients, * patients with a history of end stage renal disease, a history of heart failure or a BMI of greater than 50.

Study locations

Before you participate: Varda Clinical is an independent discovery tool, not the study sponsor or a medical provider. Eligibility can only be determined by the official study team. Discuss potential risks and benefits with a qualified healthcare professional.

Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-09-27.